Drug Co. to pay $203M in whistleblower case

Elan Corporation PLC has agreed to pay more than $203 million for the alleged illegal promotion of its epilepsy drug Zonegran. The U.S. Justice Department said the Irish drug manufacturer agreed to plead guilty to a misdemeanor for allegedly promoting Zonegran for improper uses, including mood stabilization, migraine headaches, eating disorders and weight loss. The U.S. Food and Drug